ApicHope Pharmaceutical Co., Ltd
SZSE:300723.SZ
26.51 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -566.707 | 151.795 | 262.097 | 293.415 | 223.636 | 142.529 | 207.686 | 154.819 | 135.841 | 60.401 | 39.199 | 32.324 |
| Depreciation & Amortization
| 203.547 | 182.203 | 97.45 | 73.466 | 40.677 | 37.967 | 36.055 | 33.568 | 31.189 | 28.367 | 17.634 | 13.386 |
| Deferred Income Tax
| 0 | 0 | -20.246 | -0.637 | 3.901 | -5.619 | -3.092 | -2.424 | 0.045 | -0.817 | 0 | 0 |
| Stock Based Compensation
| 0 | -10.789 | 15.809 | 13.793 | -8.035 | 4.976 | 7.161 | 0 | 0 | 33.133 | 0 | 0 |
| Change In Working Capital
| -331.314 | 47.836 | 24.522 | 45.632 | 16.651 | 49.972 | -18.019 | -64.782 | -42.564 | -112.073 | -70.407 | 83.895 |
| Accounts Receivables
| 20.926 | -12.599 | -187.227 | 27.811 | 6.964 | -12.437 | -123.429 | -38.042 | -69.405 | -45.6 | -44.788 | 50.479 |
| Inventory
| 45.038 | -168.41 | -63.054 | -2.67 | -28.41 | -3.538 | 55.508 | -34.048 | 9.434 | -33.279 | -27.133 | 7.046 |
| Accounts Payables
| 0 | 244.945 | 295.05 | -27.811 | 34.196 | 71.566 | 52.994 | 9.731 | 17.363 | -32.378 | 0 | 0 |
| Other Working Capital
| -397.278 | -16.099 | -20.246 | 48.301 | 3.901 | -5.619 | -73.527 | -30.734 | -51.998 | -78.794 | -43.274 | 76.85 |
| Other Non Cash Items
| 144.05 | 87.006 | 91.465 | 25.588 | -5.743 | 50.182 | 12.878 | 17.745 | 21.542 | 57.855 | 22.317 | 6.075 |
| Operating Cash Flow
| -550.425 | 458.051 | 475.535 | 438.101 | 275.221 | 280.65 | 238.6 | 141.349 | 146.008 | 34.55 | 8.742 | 135.681 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -319.757 | -334.458 | -605.784 | -561.232 | -314.152 | -105.216 | -256.768 | -28.488 | -28.552 | -42.326 | -112.211 | -87.584 |
| Acquisitions Net
| 0 | 0 | 0.25 | -46.279 | -5.333 | 105.436 | -3.599 | 0.03 | 187.552 | 4.8 | 0.111 | 0 |
| Purchases Of Investments
| -2,175.631 | -855.603 | -1,101.442 | -1,327.375 | -1,880 | -2,164.8 | -1,024.35 | -670 | -159 | 0 | -7.28 | 0 |
| Sales Maturities Of Investments
| 2,220.322 | 602.919 | 1,037.449 | 1,015.237 | 1,892.278 | 2,152.109 | 1,693.157 | 0 | 0.177 | 10.753 | 0.098 | 0 |
| Other Investing Activites
| 0.07 | 8.151 | 0 | 0.059 | 0.033 | -105.216 | 0.012 | 0.03 | 159 | 176.786 | -146.835 | -26.732 |
| Investing Cash Flow
| -274.996 | -578.99 | -669.526 | -919.59 | -307.174 | -117.686 | 408.451 | -698.458 | -28.376 | 145.212 | -266.227 | -114.316 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 920 | -0.881 | -132.348 | 982.578 | 86.639 | -83.115 | 0 | -67.826 | -37.214 | -40.513 | 317.562 | -42.07 |
| Common Stock Issued
| 0 | 0 | 41.652 | 123.268 | 36.52 | 0 | 0 | -13.222 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0.306 | -41.652 | -123.268 | -36.52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -108.208 | -56.632 | -56.596 | -39.263 | -31.411 | -32.183 | -41.386 | -15.579 | -18.436 | -147.908 | -20.534 | -7.156 |
| Other Financing Activities
| 4.208 | 157.273 | 98.708 | -264.239 | -1.928 | -90.363 | 43.877 | 634.185 | 0 | 4.8 | 40.091 | 1.862 |
| Financing Cash Flow
| 816 | 99.76 | -138.905 | 555.808 | 16.78 | -209.374 | 19.877 | 550.78 | -55.65 | -183.62 | 267.653 | -40.208 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 1.312 | -2.391 | 0.105 | -0.475 | 0 | 0.011 | -0.001 | -0.028 | 0.025 | 0 | 0 | 0 |
| Net Change In Cash
| -8.109 | -23.57 | -332.791 | 73.843 | -15.173 | -46.399 | 666.927 | -6.357 | 62.008 | -3.859 | 10.168 | -18.843 |
| Cash At End Of Period
| 399.405 | 407.515 | 431.084 | 763.876 | 690.032 | 705.205 | 751.604 | 84.676 | 91.033 | 29.025 | 32.884 | 22.716 |